Globus Medical Inc income statement

In fiscal 2025, Globus Medical Inc reported revenue of $2.94bn, up 16.7% on the year before, operating income of $480m (a 16.3% margin) and net income of $538m, or $3.92 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Globus Medical Inc: income statement, annual
Fiscal year	2010Dec 2010	2011Dec 2011	2012Dec 2012	2013Dec 2013	2014Dec 2014	2015Dec 2015	2016Dec 2016	2017Dec 2017	2018Dec 2018	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025	LTMJun 2026
Revenue	288	331	386	434	474	545	564	636	713	785	789	958	1,023	1,568	2,519	2,939	3,145
Cost of revenue	—	—	—	—	—	—	135	150	159	180	217	239	264	548	1,035	958	989
Gross profit	234	263	311	334	364	412	429	486	554	605	572	719	759	1,020	1,484	1,981	2,156
Research and development	21	23	28	27	31	36	45	44	55	60	85	97	73	124	164	147	147
Selling, general and administrative	123	140	169	183	189	210	222	268	312	355	355	408	432	644	981	1,178	1,217
Operating income	88	97	115	102	138	172	154	162	169	172	111	172	228	133	166	480	640
Net interest income	—	—	0	0	1	1	3	7	13	17	14	9	14	20	−4	—	—
Income before tax	88	97	115	102	139	173	157	170	189	190	126	180	243	165	121	605	660
Income tax	33	36	41	33	46	60	53	63	32	35	24	31	53	43	18	67	125
Net income	54	61	74	69	92	113	104	107	156	155	102	149	190	123	103	538	535
Diluted EPS	$0.60	$0.67	$0.80	$0.73	$0.97	$1.17	$1.08	$1.10	$1.54	$1.52	$1.01	$1.44	$1.85	$1.07	$0.75	$3.92	$3.91
Diluted shares (average)	91m	90m	92m	94m	95m	96m	96m	98m	101m	102m	101m	104m	103m	115m	138m	137m	137m
EBITDA	103	114	133	121	160	196	193	204	211	225	174	242	296	279	419	757	860

US$ millions unless shown otherwise. Fiscal quarters.

Globus Medical Inc: income statement, quarterly
Quarter	2024 Q3Sept 2024	2024 Q4Dec 2024	2025 Q1Mar 2025	2025 Q2Jun 2025	2025 Q3Sept 2025	2025 Q4Dec 2025	2026 Q1Mar 2026	2026 Q2Jun 2026
Revenue	626	657	598	745	769	826	760	790
Cost of revenue	271	263	195	249	253	261	234	241
Gross profit	355	394	403	497	517	565	526	548
Research and development	35	33	33	40	38	36	37	36
Selling, general and administrative	240	253	243	304	314	318	298	287
Operating income	48	60	97	76	137	169	150	182
Net interest income	−1	1	2	1	1	—	—	—
Income before tax	57	25	104	188	144	169	157	190
Income tax	5	−2	28	−15	25	29	33	38
Net income	52	27	75	203	119	141	124	152
Diluted EPS	$0.38	$0.19	$0.54	$1.49	$0.88	$1.02	$0.90	$1.10
EBITDA	85	128	163	117	179	238	220	223

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: GMED vs PODD GMED vs RVTY GMED vs QDEL

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Globus Medical Inc's SEC filings (10-K and 10-Q), retrieved October 20, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Globus Medical Inc.